Global Health

Rank Table by:  Country Name    Number

Rank Country Name  Number  Year Global 9,500,000 2008 1 South Africa 1,700,000 2007 2 Nigeria 750,000 2007 3 Zimbabwe 570,000 2007 4 Kenya 470,000 2007 5 Tanzania (United Rep. of) 440,000 2007 6 Mozambique 370,000 2007 7 Uganda 350,000 2007 8 Zambia 330,000 2007 9 Ethiopia 310,000 2007 10 Malawi 290,000 2007 11 Thailand 250,000 2007 12 Brazil 230,000 2007 13 China 190,000 2007 13 Cote d'Ivoire 190,000 2007 13 Russian Federation 190,000 2007 14 Cameroon 180,000 2007 15 Botswana 120,000 2007 15 Congo (Dem. Republic of) 120,000 2007 16 Ukraine 91,000 2007 17 Ghana 87,000 2007 17 Sudan 87,000 2007 18 Lesotho 85,000 2007 19 Mexico 76,000 2007 19 Myanmar 76,000 2007 20 Rwanda 68,000 2007 21 Viet Nam 67,000 2007 22 Namibia 59,000 2007 22 Swaziland 59,000 2007 23 Chad 55,000 2007 24 Colombia 54,000 2007 25 Argentina 53,000 2007 26 Burkina Faso 48,000 2007 27 Angola 47,000 2007 27 Burundi 47,000 2007 28 Central African Republic 45,000 2007 29 Indonesia 43,000 2007 30 Togo 41,000 2007 31 Cambodia 40,000 2007 32 Haiti 36,000 2007 33 Venezuela 35,000 2007 34 Mali 30,000 2007 35 Congo 29,000 2007 36 Peru 23,000 2007 37 Dominican Republic 22,000 2007 38 Guatemala 21,000 2007 38 Guinea 21,000 2007 39 Benin 20,000 2007 39 Malaysia 20,000 2007 39 Nepal 20,000 2007 39 Pakistan 20,000 2007 40 Iran (Islamic Republic of) 19,000 2007 41 Niger 16,000 2007 42 Gabon 15,000 2007 43 Sierra Leone 13,000 2007 44 Chile 12,000 2007 44 Honduras 12,000 2007 44 Senegal 12,000 2007 45 El Salvador 11,000 2007 46 Eritrea 10,000 2007 47 Poland 9,300 2007 48 Romania 8,900 2007 49 Jamaica 8,500 2007 49 Liberia 8,500 2007 50 Ecuador 7,600 2007 51 Panama 7,200 2007 52 Somalia 6,300 2007 53 Papua New Guinea 5,900 2007 54 Morocco 5,300 2007 55 Algeria 4,900 2007 56 Paraguay 4,800 2007 57 Djibouti 4,500 2007 58 Guinea-Bissau 4,400 2007 59 Belarus 4,300 2007 59 Guyana 4,300 2007 60 Serbia 3,700 2007 61 Mauritania 3,600 2007 62 Madagascar 3,200 2007 63 Equatorial Guinea 3,100 2007 63 Uruguay 3,100 2007 64 Korea (Dem. Peo. Rep. of) 2,900 2007 65 Costa Rica 2,800 2007 66 Bangladesh 2,400 2007 67 Bolivia 2,300 2007 67 Gambia 2,300 2007 68 Egypt 2,200 2007 68 Latvia 2,200 2007 69 Hungary 2,000 2007 70 Kazakhstan 1,900 2007 71 Nicaragua 1,700 2007 72 Suriname 1,600 2007 73 Mauritius 1,500 2007 74 Cuba 1,400 2007 74 Uzbekistan 1,400 2007 75 Tajikistan 1,300 2007 76 Belize 1,100 2007 76 Philippines 1,100 2007 77 Tunisia 1,000 2007 78 Lebanon 940 2007 79 Moldova (Republic of) 800 2007 80 Sri Lanka 780 2007 81 Lao People's Democratic Rep. 690 2007 82 Armenia 660 2007 83 Kyrgyzstan 610 2007 84 Azerbaijan 580 2007 85 Lithuania 550 2007 86 Georgia <500 2007 87 Fiji <200 2007 88 Bhutan <100 2007 88 Comoros <100 2007 88 Maldives <100 2007 88 Mongolia <100 2007 89 Afghanistan NA 2007 89 Albania NA 2007 89 American Samoa NA 2007 89 Andorra NA 2007 89 Anguilla NA 2007 89 Antigua and Barbuda NA 2007 89 Aruba NA 2007 89 Australia NA 2007 89 Austria NA 2007 89 Bahamas NA 2007 89 Bahrain NA 2007 89 Barbados NA 2007 89 Belgium NA 2007 89 Bermuda NA 2007 89 Bosnia and Herzegovina NA 2007 89 Bouvet Island NA 2007 89 British Indian Ocean Territory NA 2007 89 British Virgin Islands NA 2007 89 Brunei Darussalam NA 2007 89 Bulgaria NA 2007 89 Canada NA 2007 89 Cape Verde NA 2007 89 Cayman Islands NA 2007 89 Christmas Island NA 2007 89 Cocos (Keeling Islands) NA 2007 89 Cook Islands NA 2007 89 Croatia NA 2007 89 Cyprus NA 2007 89 Czech Republic NA 2007 89 Denmark NA 2007 89 Dominica NA 2007 89 Estonia NA 2007 89 Faeroe Islands NA 2007 89 Falkland Islands (Malvinas) NA 2007 89 Finland NA 2007 89 France NA 2007 89 French Guiana NA 2007 89 French Polynesia NA 2007 89 French Southern Territories and Antarctic Lands NA 2007 89 Germany NA 2007 89 Gibraltar NA 2007 89 Greece NA 2007 89 Greenland NA 2007 89 Grenada NA 2007 89 Guadeloupe NA 2007 89 Guam NA 2007 89 Heard Island and McDonald Islands NA 2007 89 Iceland NA 2007 89 India NA 2007 89 Iraq NA 2007 89 Ireland NA 2007 89 Israel NA 2007 89 Italy NA 2007 89 Japan NA 2007 89 Johnston Atoll NA 2007 89 Jordan NA 2007 89 Kiribati NA 2007 89 Korea (Republic of) NA 2007 89 Kuwait NA 2007 89 Libyan Arab Jamahiriya NA 2007 89 Liechtenstein NA 2007 89 Luxembourg NA 2007 89 Macedonia (The former Yugoslav Republic of) NA 2007 89 Malta NA 2007 89 Marshall Islands NA 2007 89 Martinique NA 2007 89 Mayotte NA 2007 89 Micronesia (Federated States of) NA 2007 89 Midway NA 2007 89 Monaco NA 2007 89 Montenegro NA 2007 89 Montserrat NA 2007 89 Nauru NA 2007 89 Netherlands NA 2007 89 Netherlands Antilles NA 2007 89 New Caledonia NA 2007 89 New Zealand NA 2007 89 Niue NA 2007 89 Norfolk Island NA 2007 89 Northern Mariana Islands NA 2007 89 Norway NA 2007 89 Oman NA 2007 89 Palau NA 2007 89 Pitcairn Island NA 2007 89 Portugal NA 2007 89 Puerto Rico NA 2007 89 Qatar NA 2007 89 Reunion NA 2007 89 Saint Helena NA 2007 89 Saint Kitts and Nevis NA 2007 89 Saint Lucia NA 2007 89 Saint Vincent and the Grenadines NA 2007 89 Samoa NA 2007 89 San Marino NA 2007 89 Sao Tome and Principe NA 2007 89 Saudi Arabia NA 2007 89 Seychelles NA 2007 89 Singapore NA 2007 89 Slovakia NA 2007 89 Slovenia NA 2007 89 Solomon Islands NA 2007 89 Spain NA 2007 89 Svalbard and Jan Mayen Islands NA 2007 89 Sweden NA 2007 89 Switzerland NA 2007 89 Syrian Arab Republic NA 2007 89 Timor Leste NA 2007 89 Tokelau NA 2007 89 Tonga NA 2007 89 Trinidad and Tobago NA 2007 89 Turkey NA 2007 89 Turkmenistan NA 2007 89 Turks and Caicos Island NA 2007 89 Tuvalu NA 2007 89 United Arab Emirates NA 2007 89 United Kingdom NA 2007 89 United States of America NA 2007 89 Vanuatu NA 2007 89 Virgin Islands (U.S.) NA 2007 89 Wake Island NA 2007 89 Wallis and Futuna Islands NA 2007 89 West Bank and Gaza NA 2007 89 Western Sahara NA 2007 89 Yemen NA 2007

Notes: The global entry above is a 2008 estimate; country entries are 2007 estimates. WHO treatment guidelines are currently being revised and treatment need for adults could change substantially. Therefore, treatment need by country was not updated to reflect 2008 estimates. The number of people who need ARV therapy in a country is estimated using statistical modelling methods that include all people who meet criteria for initiating treatment, whether or not these people know their HIV status and their eligibility for ARV therapy. The modelling methods utilize the assumption that the average time from HIV seroconversion to eligibility for ARV therapy is eight years and, without antiretroviral therapy, the average time from eligibility to death is about three years. These parameters were revised in 2007: the previous estimates were based on the assumption of seven years from seroconversion to eligibility and two years from eligibility to death in absence of treatment. WHO treatment guidelines recommend that, in resource-constrained settings, HIV-infected adults and children should start ARV therapy when infection has been confirmed and there are signs of clinically advanced disease. To estimate the number of people who are in need of ARV therapy, WHO/UNAIDS first estimates the number who need to start ARV therapy, as recommended by these guidelines. This estimate is then added to the number of people who were estimated to be receiving treatment in the previous year, and survived into the current year, to derive an estimate of the total number of people needing ARV therapy. Data were not included for countries not considered to be low- or middle-income or for countries where data were unavailable. For India, estimates of the number of people needing ARV therapy are currently being reviewed and will be adjusted, as appropriate, based on ongoing data collection and analysis.

Definitions: Antiretroviral (ARV) Drugs: Drugs that inhibit the replication of HIV. When antiretroviral drugs are given in combination, HIV replication and immune deterioration can be delayed, and survival and quality of life improved.

Antiretroviral Therapy(ART): Refers to a range of treatments that includes antiretroviral (ARV) medications. The drugs that are used in the treatment of HIV, a retrovirus, are designed to interfere with the virus' ability to replicate itself and, therefore, slow the progression of the disease. ART consists of the use of at least three antiretroviral drugs to maximally suppress HIV, the virus, and stop or slow the progression of HIV disease.

Sources: Global total available at WHO/UNAIDS/UNICEF, Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector, Progress Report, September 2009: http://www.who.int/hiv/pub/2009progressreport/en/. Country totals available at WHO/UNAIDS/UNICEF, Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector, Progress Report, June 2008: http://www.who.int/hiv/pub/2008progressreport/en/index.html.